93 related articles for article (PubMed ID: 20020126)
1. CTLA-4 +49A>G polymorphism of recipients of HLA-matched sibling allogeneic stem cell transplantation is associated with survival and relapse incidence.
Piccioli P; Balbi G; Serra M; Morabito A; Lamparelli T; Gobbi M; Laurent S; Dozin B; Bruzzi P; Ferraris AM; Bacigalupo A; Notaro R; Pistillo MP
Ann Hematol; 2010 Jun; 89(6):613-8. PubMed ID: 20020126
[TBL] [Abstract][Full Text] [Related]
2. Functional polymorphism of CTLA-4 and ICOS genes in allogeneic hematopoietic stem cell transplantation.
Wu J; Tang JL; Wu SJ; Lio HY; Yang YC
Clin Chim Acta; 2009 May; 403(1-2):229-33. PubMed ID: 19332044
[TBL] [Abstract][Full Text] [Related]
3. Effect of donor CTLA-4 alleles and haplotypes on graft-versus-host disease occurrence in Tunisian patients receiving a human leukocyte antigen-identical sibling hematopoietic stem cell transplant.
Sellami MH; Bani M; Torjemane L; Kaabi H; Ladeb S; Ben Othmane T; Hmida S
Hum Immunol; 2011 Feb; 72(2):139-43. PubMed ID: 21081144
[TBL] [Abstract][Full Text] [Related]
4. Donor CTLA-4 genotype influences clinical outcome after T cell-depleted allogeneic hematopoietic stem cell transplantation from HLA-identical sibling donors.
Bosch-Vizcaya A; Pérez-García A; Brunet S; Solano C; Buño I; Guillem V; Martínez-Laperche C; Sanz G; Barrenetxea C; Martínez C; Tuset E; Lloveras N; Coll R; Guardia R; González Y; Roncero JM; Bustins A; Gardella S; Fernández C; Buch J; Gallardo D;
Biol Blood Marrow Transplant; 2012 Jan; 18(1):100-5. PubMed ID: 21703972
[TBL] [Abstract][Full Text] [Related]
5. Donor KIR3DL1/3DS1 gene and recipient Bw4 KIR ligand as prognostic markers for outcome in unrelated hematopoietic stem cell transplantation.
Gagne K; Busson M; Bignon JD; Balère-Appert ML; Loiseau P; Dormoy A; Dubois V; Perrier P; Jollet I; Bois M; Masson D; Moine A; Absi L; Blaise D; Charron D; Raffoux C;
Biol Blood Marrow Transplant; 2009 Nov; 15(11):1366-75. PubMed ID: 19822295
[TBL] [Abstract][Full Text] [Related]
6. Impact of vitamin D receptor gene polymorphisms on clinical outcomes of HLA-matched sibling hematopoietic stem cell transplantation.
Cho HJ; Shin DY; Kim JH; Bae JY; Lee KH; See CJ; Kim N; Park EK; Ra EK; Lee JE; Hong YC; Kim HK; Park SS; Yoon SS; Lee DS; Han KS; Park MH; Park S; Kim BK; Kim I
Clin Transplant; 2012; 26(3):476-83. PubMed ID: 22035017
[TBL] [Abstract][Full Text] [Related]
7. Does younger donor age affect the outcome of reduced-intensity allogeneic hematopoietic stem cell transplantation for hematologic malignancies beneficially?
Mehta J; Gordon LI; Tallman MS; Winter JN; Evens AM; Frankfurt O; Williams SF; Grinblatt D; Kaminer L; Meagher R; Singhal S
Bone Marrow Transplant; 2006 Jul; 38(2):95-100. PubMed ID: 16751789
[TBL] [Abstract][Full Text] [Related]
8. Equivalent survival for sibling and unrelated donor allogeneic stem cell transplantation for acute myelogenous leukemia.
Moore J; Nivison-Smith I; Goh K; Ma D; Bradstock K; Szer J; Durrant S; Schwarer A; Bardy P; Herrmann R; Dodds A
Biol Blood Marrow Transplant; 2007 May; 13(5):601-7. PubMed ID: 17448920
[TBL] [Abstract][Full Text] [Related]
9. [Effects and prognostic factors of HLA-matched sibling donor allogeneic hematopoietic stem cell transplantation for chronic myelogenous leukemia].
Tong XZ; Li J; Tan EX; Zhang GC; Wu XY; Peng AH; Zheng D; Zou WY; Hong WD; Luo SK
Zhonghua Zhong Liu Za Zhi; 2006 Jul; 28(7):545-8. PubMed ID: 17147125
[TBL] [Abstract][Full Text] [Related]
10. Immunogenetic factors in donors and patients that affect the outcome of hematopoietic stem cell transplantation.
Madrigal A; Shaw BE
Blood Cells Mol Dis; 2008; 40(1):40-3. PubMed ID: 17964196
[TBL] [Abstract][Full Text] [Related]
11. A CT60G>A polymorphism in the CTLA-4 gene of the recipient may confer susceptibility to acute graft versus host disease after allogeneic hematopoietic stem cell transplantation.
Karabon L; Markiewicz M; Partyka A; Pawlak-Adamska E; Tomkiewicz A; Dzierzak-Mietla M; Kyrcz-Krzemien S; Frydecka I
Immunogenetics; 2015 Jun; 67(5-6):295-304. PubMed ID: 25940108
[TBL] [Abstract][Full Text] [Related]
12. Polymorphisms of the methylenetetrahydrofolate reductase gene and clinical outcomes in HLA-matched sibling allogeneic hematopoietic stem cell transplantation.
Kim I; Lee KH; Kim JH; Ra EK; Yoon SS; Hong YC; Park SS; Kim CS; Park S; Kim BK
Ann Hematol; 2007 Jan; 86(1):41-8. PubMed ID: 17028897
[TBL] [Abstract][Full Text] [Related]
13. [Distribution of immunoglobulin like receptor gene in Han population in China and the impact thereof on the HLA-identical sibling hematopoietic stem cell transplantation].
Dou LP; DA WM; Zhao DD; Wang C; Lu XC; Kang HY; Yan P; Wang FF; Zhu HY; Li HH; Gao CJ; Yu L
Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(44):3111-4. PubMed ID: 18269867
[TBL] [Abstract][Full Text] [Related]
14. HLA Association with hematopoietic stem cell transplantation outcome: the number of mismatches at HLA-A, -B, -C, -DRB1, or -DQB1 is strongly associated with overall survival.
Loiseau P; Busson M; Balere ML; Dormoy A; Bignon JD; Gagne K; Gebuhrer L; Dubois V; Jollet I; Bois M; Perrier P; Masson D; Moine A; Absi L; Reviron D; Lepage V; Tamouza R; Toubert A; Marry E; Chir Z; Jouet JP; Blaise D; Charron D; Raffoux C
Biol Blood Marrow Transplant; 2007 Aug; 13(8):965-74. PubMed ID: 17640601
[TBL] [Abstract][Full Text] [Related]
15. Matched unrelated or matched sibling donors result in comparable survival after allogeneic stem-cell transplantation in elderly patients with acute myeloid leukemia: a report from the cooperative German Transplant Study Group.
Schetelig J; Bornhäuser M; Schmid C; Hertenstein B; Schwerdtfeger R; Martin H; Stelljes M; Hegenbart U; Schäfer-Eckart K; Füssel M; Wiedemann B; Thiede C; Kienast J; Baurmann H; Ganser A; Kolb HJ; Ehninger G
J Clin Oncol; 2008 Nov; 26(32):5183-91. PubMed ID: 18768435
[TBL] [Abstract][Full Text] [Related]
16. Clinical significance of HLA-E*0103 homozygosity on survival after allogeneic hematopoietic stem-cell transplantation.
Danzer M; Polin H; Pröll J; Haunschmid R; Hofer K; Stabentheiner S; Hackl C; Kasparu H; König J; Hauser H; Binder M; Weiss R; Gabriel C; Krieger O
Transplantation; 2009 Aug; 88(4):528-32. PubMed ID: 19696636
[TBL] [Abstract][Full Text] [Related]
17. Association of vitamin D receptor polymorphisms with the outcome of allogeneic haematopoietic stem cell transplantation.
Bogunia-Kubik K; Middleton P; Norden J; Dickinson A; Lange A
Int J Immunogenet; 2008 Jun; 35(3):207-13. PubMed ID: 18312595
[TBL] [Abstract][Full Text] [Related]
18. Possible impact of MADCAM1 gene single nucleotide polymorphisms to the outcome of allogeneic hematopoietic stem cell transplantation.
Ambruzova Z; Mrazek F; Raida L; Stahelova A; Faber E; Indrak K; Petrek M
Hum Immunol; 2009 Jun; 70(6):457-60. PubMed ID: 19286444
[TBL] [Abstract][Full Text] [Related]
19. Allogeneic stem cell transplantation for adults with myelodysplastic syndromes: importance of pretransplant disease burden.
Warlick ED; Cioc A; Defor T; Dolan M; Weisdorf D
Biol Blood Marrow Transplant; 2009 Jan; 15(1):30-8. PubMed ID: 19135940
[TBL] [Abstract][Full Text] [Related]
20. CTLA-4 polymorphism and clinical outcome post allogeneic hematopoietic stem cell transplantation.
Mossallam GI; Samra MA
Hum Immunol; 2013 Dec; 74(12):1643-8. PubMed ID: 23973330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
